Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

Julia TCW, Lu Qian, Nina H. Pipalia, Michael J. Chao, Shuang A. Liang, Yang Shi, Bharat R. Jain, Sarah E. Bertelsen, Manav Kapoor, Edoardo Marcora, Elizabeth Sikora, Elizabeth J. Andrews, Alessandra C. Martini, Celeste M. Karch, Elizabeth Head, David M. Holtzman, Bin Zhang, Minghui Wang, Frederick R. Maxfield, Wayne W. PoonAlison M. Goate

Research output: Contribution to journalArticlepeer-review

107 Scopus citations


The impact of apolipoprotein E ε4 (APOE4), the strongest genetic risk factor for Alzheimer's disease (AD), on human brain cellular function remains unclear. Here, we investigated the effects of APOE4 on brain cell types derived from population and isogenic human induced pluripotent stem cells, post-mortem brain, and APOE targeted replacement mice. Population and isogenic models demonstrate that APOE4 local haplotype, rather than a single risk allele, contributes to risk. Global transcriptomic analyses reveal human-specific, APOE4-driven lipid metabolic dysregulation in astrocytes and microglia. APOE4 enhances de novo cholesterol synthesis despite elevated intracellular cholesterol due to lysosomal cholesterol sequestration in astrocytes. Further, matrisome dysregulation is associated with upregulated chemotaxis, glial activation, and lipid biosynthesis in astrocytes co-cultured with neurons, which recapitulates altered astrocyte matrisome signaling in human brain. Thus, APOE4 initiates glia-specific cell and non-cell autonomous dysregulation that may contribute to increased AD risk.

Original languageEnglish
Pages (from-to)2213-2233.e25
Issue number13
StatePublished - Jun 23 2022


  • APOE
  • Alzheimer
  • astrocytes
  • cholesterol
  • genetic heterogeneity
  • haplotypes
  • iPSC disease modeling
  • inflammation
  • matrisome
  • microglia


Dive into the research topics of 'Cholesterol and matrisome pathways dysregulated in astrocytes and microglia'. Together they form a unique fingerprint.

Cite this